BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9338015)

  • 1. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
    Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
    Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
    Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
    Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration.
    Kay MA; Holterman AX; Meuse L; Gown A; Ochs HD; Linsley PS; Wilson CB
    Nat Genet; 1995 Oct; 11(2):191-7. PubMed ID: 7550348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
    Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
    Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
    Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration.
    Wilson CB; Embree LJ; Schowalter D; Albert R; Aruffo A; Hollenbaugh D; Linsley P; Kay MA
    J Virol; 1998 Sep; 72(9):7542-50. PubMed ID: 9696851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
    Quattrocchi E; Dallman MJ; Feldmann M
    Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
    Takayama T; Morelli AE; Robbins PD; Tahara H; Thomson AW
    Gene Ther; 2000 Aug; 7(15):1265-73. PubMed ID: 10918497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
    Stein CS; Pemberton JL; van Rooijen N; Davidson BL
    Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina.
    Ali RR; Reichel MB; Byrnes AP; Stephens CJ; Thrasher AJ; Baker D; Hunt DM; Bhattacharya SS
    Gene Ther; 1998 Nov; 5(11):1561-5. PubMed ID: 9930310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
    Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
    J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
    Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
    Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery.
    Hoffman LM; Maguire AM; Bennett J
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2224-33. PubMed ID: 9344345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified AdCTLA-4 vector blocks alloimmune response in vitro.
    Zamir G; Gelman AE; Debonera F; Hardwigsen J; Que X; Aldeguer X; Martin M; Shaked A; Olthoff KM
    J Surg Res; 2001 May; 97(2):155-8. PubMed ID: 11341792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.